Life ScienceCompany
Symbiomix Therapeutics Ownership
Who owns Symbiomix Therapeutics?
Symbiomix Therapeutics is owned by Eight Roads and Lupin. It was acquired on October 11, 2017.
Is Symbiomix Therapeutics PE-backed?
Yes. Symbiomix Therapeutics is owned by private equity investors Eight Roads and Lupin.
Symbiomix Therapeutics Business Overview
Where is Symbiomix Therapeutics headquartered?
Symbiomix Therapeutics is headquartered in Newark, New Jersey.
What sector is Symbiomix Therapeutics in?
Symbiomix Therapeutics is a life science company.
When was Symbiomix Therapeutics founded?
Symbiomix Therapeutics was founded in 2012.
Life Science M&A Summary in 2017
Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2017. The largest life science acquisition in 2017 was Actelion - which was acquired by Johnson & Johnson for $30.0B.
Join Mergr to view all 248 acquisitions of life science companies in 2017, including 23 acquisitions by private equity firms, and 225 by strategics.